Dravet syndrome is not one of the most frequent severe epilepsies affecting infants during
the first year of life. In the most recent epidemiological study, in Sweden, its estimated�…

Dravet syndrome is a rare form of epilepsy largely refractory to current antiepileptic
medications. The only precedents of randomized placebo-controlled trials in Dravet�…

Background: This report focuses on the treatment histories of 21 patients diagnosed with
Dravet syndrome (DRVT) under the care of the Mother and Child Institute in Warsaw. This�…

Objective Dravet syndrome is a developmental and epileptic encephalopathy characterized
by severe and drug‐resistant seizures in early childhood, followed by developmental delay�…

Dravet syndrome is a rare and progressive epileptic encephalopathy of infancy. Stiripentol
reduces the seizure frequency in patients with Dravet syndrome. We evaluated the clinical�…

Aim To assess long‐term safety and efficacy of stiripentol as an antiepileptic medication for
people with Dravet syndrome. Method A prospective, observational open‐label study (2003�…

Dravet syndrome is one of the most severe epilepsy syndromes of early childhood, and it
comes with very high morbidity and mortality. The typical presentation is characterized by�…

Dravet syndrome (DS) is a severe genetic epilepsy characterized by early-life onset,
seizures, and neurodevelopmental delays that have major impacts on affected children. DS�…

Dravet syndrome is among the most challenging electroclinical syndromes. There is a high
likelihood of recurrent status epilepticus; seizures are medically refractory; and patients have�…

Introduction The efficacy of stiripentol in Dravet syndrome children was evidenced in two
randomized, double-blind, placebo-controlled, phase 3 studies, namely STICLO France�…